Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Metastatic Breastcancer × Breast × Clear all

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1116 Triple Negative Breast Neoplasms 145 Neoplasm Metastasis 98 Carcinoma, Non-Small-Cell Lung 85 Ovarian Neoplasms 80 Neoplasms 73 Lung Neoplasms 64 Colorectal Neoplasms 59 Melanoma 58 Stomach Neoplasms 44 Pancreatic Neoplasms 43 Breast Neoplasms, Male 43 Prostatic Neoplasms 42 Carcinoma, Renal Cell 36 Squamous Cell Carcinoma of Head and Neck 34 Sarcoma 29 Colonic Neoplasms 29 Endometrial Neoplasms 28 Head and Neck Neoplasms 26 Brain Neoplasms 24 Urinary Bladder Neoplasms 22 Esophageal Neoplasms 21 Carcinoma, Ovarian Epithelial 21 Carcinoma, Intraductal, Noninfiltrating 20 Lymphoma, Non-Hodgkin 19 Uterine Cervical Neoplasms 17 Recurrence 17 Inflammatory Breast Neoplasms 17 Multiple Myeloma 16 Lymphoma 16

Interventions

Dehydroepiandrosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02000375 2016-09-29

ARTT

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Metastatic Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡